U.S. Court of Appeals for the Federal Circuit, 2024

Allele Biotechnology and Pharmaceuticals, Inc. v. Regeneron Pharmaceuticals, Inc.

Allele Biotechnology and Pharmaceuticals, Inc. v. Regeneron Pharmaceuticals, Inc.
U.S. Court of Appeals for the Federal Circuit · Decided December 31, 2024

Allele Biotechnology and Pharmaceuticals, Inc. v. Regeneron Pharmaceuticals, Inc.

Opinion

Case: 25-1117 Document: 13 Page: 1 Filed: 12/31/2024

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS, INC., Plaintiff-Appellee v. REGENERON PHARMACEUTICALS, INC., Defendant-Appellant ______________________ 2025-1117 ______________________ Appeal from the United States District Court for the Southern District of New York in No. 7:20-cv-08255-PMH, Judge Philip M. Halpern. ______________________ ORDER The parties having so agreed, it is ordered that: (1) The proceeding is DISMISSED under Fed. R. App. P. 42 (b).

Case: 25-1117 Document: 13 Page: 2 Filed: 12/31/2024

2 ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS, INC. V. REGENERON PHARMACEUTICALS, INC.

(2) Each side shall bear their own costs.

FOR THE COURT

December 31, 2024 Date

ISSUED AS A MANDATE: December 31, 2024

Case-law data current through December 31, 2025. Source: CourtListener bulk data.